SECAUCUS, N.J. and HARTFORD, Conn., Sept. 29, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired the outreach lab services operations of two hospitals of Hartford HealthCare (HHC), The William W. Backus Hospital and The Hospital of Central Connecticut. HHC is an integrated health care system with five acute care hospitals in Connecticut.
Quest and HHC completed the acquisition following approval to proceed from the state of Connecticut's Office of Health Care Access. The acquisition will enable physicians and patients in Connecticut to directly access Quest's broader range of testing services, including several proprietary advanced diagnostic services, as well as an expanded network of patient service centers.
Testing performed by the two hospitals will transition to Quest's full-service clinical laboratory in Marlborough, Mass, as well as rapid response labs in Wallingford, Torrington, Stratford, Hartford and Norwich, Conn. Additional terms were not disclosed.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
The transaction builds on a long-standing and productive relationship between Quest and HHC. In 2016, Quest acquired the outreach laboratory service business of Clinical Laboratory Partners, which was a wholly-owned subsidiary of HHC at the time.
"We are confident our physicians and patients will be in very good hands," said Bimal Patel, President of Backus Hospital and Lucille Janatka, President of The Hospital of Central Connecticut. "Quest is the world leader in laboratory services and is extremely capable of continuing our tradition of patient-centered care and excellent customer service. We also thank our lab employees, and our dedicated physicians and patients at Backus and the Hospital of Central Connecticut for all they have done over the years to make our outreach laboratory business such a success."
"This transaction builds on the strong relationship we've built with Hartford HealthCare, as well as providers and patients across the region who benefit from greater access to Quest's diagnostic insights and innovations," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "It is also the fifth strategically aligned, accretive acquisition we've announced in 2017, delivering on our two-point strategy to accelerate growth and drive operational excellence, while strengthening our presence in New England."
About Hartford HealthCare
